Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.
2.

[Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].

Guo M, Xi G, Yang N, Yao H.

Zhonghua Gan Zang Bing Za Zhi. 2014 Aug;22(8):631-5. doi: 10.3760/cma.j.issn.1007-3418.2014.08.016. Chinese.

PMID:
25243967
4.
5.

Relationship between β-cell function, metabolic control, and microvascular complications in type 2 diabetes mellitus.

Zhao L, Ma J, Wang S, Xie Y.

Diabetes Technol Ther. 2015 Jan;17(1):29-34. doi: 10.1089/dia.2014.0214.

PMID:
25574593
6.

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N.

Diabetes. 2001 Aug;50(8):1844-50.

7.

Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.

Bedogni G, Gastaldelli A, Manco M, De Col A, Agosti F, Tiribelli C, Sartorio A.

Nutr Metab Cardiovasc Dis. 2012 Feb;22(2):120-6. doi: 10.1016/j.numecd.2010.05.003. Epub 2010 Sep 28.

PMID:
20880682
8.

Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease?

Sargin M, Uygur-Bayramiçli O, Sargin H, Orbay E, Yayla A.

J Clin Gastroenterol. 2003 Nov-Dec;37(5):399-402.

PMID:
14564188
9.

Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease.

Hatziagelaki E, Karageorgopoulos DE, Chounta A, Tsiavou A, Falagas ME, Dimitriadis G.

Exp Diabetes Res. 2012;2012:351974. doi: 10.1155/2012/351974. Epub 2011 Sep 21.

10.

Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).

Ortiz-Lopez C, Lomonaco R, Orsak B, Finch J, Chang Z, Kochunov VG, Hardies J, Cusi K.

Diabetes Care. 2012 Apr;35(4):873-8. doi: 10.2337/dc11-1849. Epub 2012 Feb 28.

11.

Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.

Zhang LY, Jin YJ, Jin QS, Lin LY, Zhang DD, Kong LL.

Gene. 2013 Oct 25;529(2):340-4. doi: 10.1016/j.gene.2013.08.001. Epub 2013 Aug 14.

PMID:
23954219
12.

[Insulin resistance and islet beta cell function in type 2 diabetes mellitus and non alcoholic fatty liver disease.].

Li FP, Zhang SQ, Wang F, Huang YQ, Fu ZZ, Yan L.

Zhonghua Nei Ke Za Zhi. 2009 Nov;48(11):940-3. Chinese.

PMID:
20079327
13.

[Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].

Liu J, Li YB, Shao H, Li YX, Yuan YH, Xiao YB, Weng JP.

Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1252-5. Chinese.

PMID:
17686259
14.

Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker.

Firneisz G, Varga T, Lengyel G, Fehér J, Ghyczy D, Wichmann B, Selmeci L, Tulassay Z, Rácz K, Somogyi A.

PLoS One. 2010 Aug 18;5(8):e12226. doi: 10.1371/journal.pone.0012226.

17.

Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.

Lou DJ, Zhu QQ, Si XW, Guan LL, You QY, Yu ZM, Zhang AZ.

J Diabetes Complications. 2014 Sep-Oct;28(5):711-4. doi: 10.1016/j.jdiacomp.2014.04.008. Epub 2014 Apr 18. Erratum in: J Diabetes Complications. 2015 Jan-Feb;29(1):158. Li, Duo [Deleted].

PMID:
24927647
18.

High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.

Portillo-Sanchez P, Bril F, Maximos M, Lomonaco R, Biernacki D, Orsak B, Subbarayan S, Webb A, Hecht J, Cusi K.

J Clin Endocrinol Metab. 2015 Jun;100(6):2231-8. doi: 10.1210/jc.2015-1966. Epub 2015 Apr 17.

PMID:
25885947
19.

Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease.

Yun JW, Cho YK, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI.

Liver Int. 2009 Apr;29(4):525-9. doi: 10.1111/j.1478-3231.2008.01920.x.

20.

Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion.

Lee WJ, Ser KH, Chong K, Lee YC, Chen SC, Tsou JJ, Chen JC, Chen CM.

Surgery. 2010 May;147(5):664-9. doi: 10.1016/j.surg.2009.10.059. Epub 2009 Dec 11.

PMID:
20004451

Supplemental Content

Support Center